Published in Trans Ophthalmol Soc U K on January 01, 1983
Current perspectives on ophthalmic mycoses. Clin Microbiol Rev (2003) 3.18
Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc (1995) 2.67
Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective study. Br J Ophthalmol (1987) 0.84
Postmortem histological survey of the ocular lesions in a British population of AIDS patients. Br J Ophthalmol (2000) 0.81
Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc (1990) 0.80
Candidal retinitis in a gynecologic patient. Infect Dis Obstet Gynecol (1995) 0.75
Optical coherence tomography. Science (1991) 57.87
Optical coherence tomography of the human retina. Arch Ophthalmol (1995) 8.90
Ultrahigh-resolution ophthalmic optical coherence tomography. Nat Med (2001) 7.38
Imaging of macular diseases with optical coherence tomography. Ophthalmology (1995) 7.07
In vivo retinal imaging by optical coherence tomography. Opt Lett (1993) 5.18
Topography of diabetic macular edema with optical coherence tomography. Ophthalmology (1998) 5.00
Optical coherence tomography of macular holes. Ophthalmology (1995) 4.64
Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol (1995) 4.47
Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography. Arch Ophthalmol (1994) 4.38
Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology (1996) 3.66
Herpes zoster ophthalmicus. Surv Ophthalmol (1992) 3.56
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol (1999) 3.30
PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res (1997) 3.15
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol (1999) 2.69
A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol (1997) 2.64
Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology (1994) 2.51
Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med (2001) 2.45
Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology (1996) 2.44
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol (1998) 2.39
Irinotecan therapy in adults with recurrent or progressive malignant glioma. J Clin Oncol (1999) 2.23
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol (1991) 2.05
Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol (1995) 2.03
Evaluation of coexisting optic nerve head drusen and glaucoma with optical coherence tomography. Ophthalmology (1997) 2.03
Retinal nerve fibre layer thickness measurement reproducibility improved with spectral domain optical coherence tomography. Br J Ophthalmol (2009) 1.97
A malignant glaucoma-like syndrome following pars plana vitrectomy. Ophthalmology (1999) 1.93
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res (1997) 1.89
Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg (1991) 1.81
A new quality assessment parameter for optical coherence tomography. Br J Ophthalmol (2006) 1.78
Evaluation of focal defects of the nerve fiber layer using optical coherence tomography. Ophthalmology (1999) 1.70
Imaging of the retinal nerve fibre layer for glaucoma. Br J Ophthalmol (2008) 1.65
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol (1993) 1.62
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty. Ophthalmology (1998) 1.61
Alterations of the TP53 gene in human gliomas. Cancer Res (1994) 1.58
Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology (1993) 1.54
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. Br J Cancer (2009) 1.49
Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration. Br J Ophthalmol (2006) 1.49
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene (1995) 1.49
Thromboembolic complications after Fontan operations. Circulation (1995) 1.49
Ultrastructure and clinicopathologic correlation of idiopathic preretinal macular fibrosis. Am J Ophthalmol (1975) 1.47
Subarachnoid hemorrhage from intracranial dissecting aneurysm. J Neurosurg (1984) 1.39
Giant cavernous hemangioma of the face. Arch Ophthalmol (1994) 1.39
Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol (2001) 1.38
Projection OCT fundus imaging for visualising outer retinal pathology in non-exudative age-related macular degeneration. Br J Ophthalmol (2008) 1.38
Drusen of the optic disc. A retrospective study in cadaver eyes. Br J Ophthalmol (1975) 1.38
Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol (1993) 1.35
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors. Proc Natl Acad Sci U S A (2000) 1.32
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol (1998) 1.32
Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol (1987) 1.25
Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer (1992) 1.24
Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31. Ophthalmology (1995) 1.22
Drusen of the optic disc. Surv Ophthalmol (1977) 1.21
Posterior fossa arteriovenous malformations. J Neurosurg (1986) 1.21
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J Clin Oncol (2000) 1.19
Shadow cells in an intracranial dermoid cyst. Arch Pathol Lab Med (1995) 1.18
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats. Clin Cancer Res (2000) 1.17
Failed aneurysm surgery. Reoperation in 115 cases. J Neurosurg (1984) 1.17
Effect of optic nerve head drusen on nerve fiber layer thickness. Ophthalmology (1998) 1.16
An epidemiologic evaluation of leprosy in New York City. JAMA (1982) 1.14
Scan quality effect on glaucoma discrimination by glaucoma imaging devices. Br J Ophthalmol (2009) 1.13
Fiber dissection technique: lateral aspect of the brain. Neurosurgery (2000) 1.13
Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology (1991) 1.13
Diagnosis of phacoanaphylactic endophthalmitis by fine needle aspiration biopsy. Ophthalmic Surg Lasers (1999) 1.12
Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy. Neurology (1997) 1.12
A histopathologic study of retinal arterial aneurysms. Am J Ophthalmol (1978) 1.12
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol (1998) 1.12
Ganglioglioma: a clinical study with long-term follow-up. Surg Neurol (1991) 1.08
Dorsal root entry zone lesions for the treatment of post-herpetic neuralgia. J Neurosurg (1984) 1.07
Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol (1983) 1.07
Subretinal neovascularisation in ocular toxoplasmosis. Br J Ophthalmol (1982) 1.06
Removal of intravitreous cysticerci from the surface of the optic nervehead. A pars plana approach. Arch Ophthalmol (1980) 1.06
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. Br J Cancer (2012) 1.06
Tonometry in adults and children. A manometric evaluation of pneumatonometry, applanation, and TonoPen in vitro and in vivo. Ophthalmology (1998) 1.06
Parasitic lesion of the insula suggesting cerebral sparganosis: case report. Neuroradiology (2000) 1.05
Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma. Clin Neuropathol (2004) 1.04
Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy. Surv Ophthalmol (1982) 1.03
Ocular penetration of 5-fluorocytosine. Invest Ophthalmol Vis Sci (1978) 1.02
Solitary eosinophilic granuloma invading the clivus of an adult: case report. Neurosurgery (1992) 0.99
Endogenous ocular aspergillosis. Ophthalmologica (1974) 0.99
External ocular pigmentation. Int Ophthalmol Clin (1971) 0.99
Drusen of the optic disc. A histopathological study. Trans Ophthalmol Soc U K (1975) 0.99
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol (2001) 0.98
Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. Neuro Oncol (2000) 0.98
Metastatic carcinoma of the iris. Am J Ophthalmol (1975) 0.98
Circadian rhythms in rat mid-brain and caudate nucleus biogenic amine levels. J Physiol (1968) 0.97
Systemic antiviral drugs used in ophthalmology. Surv Ophthalmol (1992) 0.97
The retinal lesions of the acquired immune deficiency syndrome. Trans Am Ophthalmol Soc (1984) 0.97
Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis. Acta Neuropathol (2000) 0.97
Seizure outcome after temporal lobectomy for temporal lobe epilepsy: a Kaplan-Meier survival analysis. Neurology (2000) 0.97
Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. Curr Opin Pediatr (2001) 0.95
Tuberculoma of the choroid. Ophthalmology (1980) 0.95
Sialyl Lewis X, Lewis X, and N-acetyllactosamine expression on normal and glaucomatous eyes. Curr Eye Res (1999) 0.95
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1. Clin Cancer Res (1999) 0.94
Exogenous Moraxella liquefaciens endophthalmitis. Ophthalmologica (1975) 0.94
Epithelial implantation membrane on the iris surface following cataract extraction with report of two cases. Am J Ophthalmol (1971) 0.93
Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke. Cancer (1999) 0.93
Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia (1999) 0.93
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report. J Neurooncol (1995) 0.93
A study of family practice in New York City. J Fam Pract (1983) 0.92